AVITA Medical, Inc. financial data

Symbol
RCEL on Nasdaq, AVHHL on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
28159 Avenue Stanford, Suite 220, Valencia, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Avita Therapeutics, Inc. (to 12/10/2020), Avita Medical, Ltd. (to 6/30/2020)
Latest financial report
10-K - Q4 2024 - Feb 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 445 % -33.8%
Quick Ratio 43.5 % +38.2%
Debt-to-equity 370 % +769%
Return On Equity -338 % -517%
Return On Assets -71.5 % -87.8%
Operating Margin -88.1 % -3.54%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.4M shares +2.53%
Common Stock, Shares, Outstanding 26.4M shares +2.62%
Entity Public Float 203M USD -52.9%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 25.9M shares +2.18%
Weighted Average Number of Shares Outstanding, Diluted 25.9M shares +2.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 64.3M USD +28.1%
Cost of Revenue 9.09M USD +16.9%
Research and Development Expense 20.4M USD -2.21%
Selling and Marketing Expense 58.2M USD +56.1%
General and Administrative Expense 33.2M USD +17.2%
Operating Income (Loss) -56.6M USD -32.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -61.8M USD -75%
Income Tax Expense (Benefit) 54K USD -18.2%
Net Income (Loss) Attributable to Parent -61.8M USD -74.8%
Earnings Per Share, Basic -2.39 USD/shares -70.7%
Earnings Per Share, Diluted -2.39 USD/shares -70.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.1M USD -36.5%
Marketable Securities, Current 21.8M USD -67.4%
Cash, Cash Equivalents, and Short-term Investments 35.9M USD
Accounts Receivable, after Allowance for Credit Loss, Current 11.8M USD +53.8%
Inventory, Net 7.27M USD +29.9%
Other Assets, Current 8K USD -98.5%
Assets, Current 57M USD -45.2%
Property, Plant and Equipment, Net 10M USD +434%
Operating Lease, Right-of-Use Asset 3.57M USD +46.4%
Intangible Assets, Net (Excluding Goodwill) 5.57M USD +1044%
Other Assets, Noncurrent 546K USD +53.8%
Assets 79.7M USD -28.6%
Liabilities, Current 20.2M USD +52.7%
Contract with Customer, Liability, Noncurrent 324K USD -9.24%
Operating Lease, Liability, Noncurrent 2.84M USD +66.9%
Liabilities 75M USD +21.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.94M USD -2.76%
Retained Earnings (Accumulated Deficit) -360M USD -20.8%
Stockholders' Equity Attributable to Parent 4.5M USD -90.8%
Liabilities and Equity 79.7M USD -28.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.9M USD -130%
Net Cash Provided by (Used in) Financing Activities 631K USD +269%
Net Cash Provided by (Used in) Investing Activities 15.1M USD -19.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 26.4M shares +2.62%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.17M USD -152%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14.1M USD -36.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.36K USD
Deferred Tax Assets, Valuation Allowance 60.4M USD -4.64%
Deferred Tax Assets, Gross 61.3M USD -4.16%
Operating Lease, Liability 3.74M USD +44%
Depreciation 1M USD +67.5%
Payments to Acquire Property, Plant, and Equipment 1.15M USD +304%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -61.9M USD -37.9%
Lessee, Operating Lease, Liability, to be Paid 4.63M USD +53.8%
Operating Lease, Liability, Current 900K USD +0.56%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.13M USD +52.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.22M USD +12.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +11.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 888K USD +116%
Lessee, Operating Lease, Liability, to be Paid, Year Three 773K USD +13%
Deferred Tax Assets, Operating Loss Carryforwards 45.2M USD -10.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 658K USD +107%
Operating Lease, Payments 991K USD +21.4%
Additional Paid in Capital 368M USD +5.01%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 93K USD +166%
Depreciation, Depletion and Amortization 203K USD +50.4%
Deferred Tax Assets, Net of Valuation Allowance 904K USD +44.9%
Share-based Payment Arrangement, Expense 13.5M USD +61%
Interest Expense 5.18M USD +13490%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%